Cargando…

VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases

Neurosecretory protein VGF (non-acronymic) belongs to the granin family of neuropeptides. VGF and VGF-derived peptides have been repeatedly identified in well-powered and well-designed multi-omic studies as dysregulated in neurodegenerative and psychiatric diseases. New therapeutics is urgently need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinn, James P, Kandigian, Savannah E, Trombetta, Bianca A, Arnold, Steven E, Carlyle, Becky C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578498/ https://www.ncbi.nlm.nih.gov/pubmed/34778762 http://dx.doi.org/10.1093/braincomms/fcab261

Ejemplares similares

Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias
por: Carlyle, Becky C., et al.
Publicado: (2018)

Proteomic characterization of post-mortem human brain tissue following ultracentrifugation-based subcellular fractionation
por: Kandigian, Savannah E., et al.
Publicado: (2022)

Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review
por: Alqarni, Saleha, et al.
Publicado: (2022)

VGF: a biomarker and potential target for the treatment of neuropathic pain?
por: Soliman, Nadia, et al.
Publicado: (2019)

Neuroendocrine Role for VGF
por: Lewis, Jo E., et al.
Publicado: (2015)

Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics
por: Carlyle, Becky C., et al.
Publicado: (2021)

The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease
por: Trombetta, Bianca A., et al.
Publicado: (2018)

NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders
por: Yang, Dongxue, et al.
Publicado: (2016)

Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease
por: Carlyle, Becky C., et al.
Publicado: (2022)

IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology
por: Bigarré, Inès M., et al.
Publicado: (2021)

VGF expression by T lymphocytes in patients with Alzheimer's disease
por: Busse, Stefan, et al.
Publicado: (2015)

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
por: Kivisäkk, Pia, et al.
Publicado: (2022)

VGF function in depression and antidepressant efficacy
por: Jiang, Cheng, et al.
Publicado: (2017)

Age-related increase of VGF-expression in T lymphocytes
por: Busse, Stefan, et al.
Publicado: (2014)

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
por: Gentile, Giulia, et al.
Publicado: (2022)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Reviews on biomarker studies in psychiatric and neurodegenerative disorders
por: Guest, Paul C
Publicado: (2019)

Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease
por: Beckmann, Noam D., et al.
Publicado: (2020)

VGF and striatal cell damage in in vitro and in vivo models of Huntington’s disease
por: Noda, Yasuhiro, et al.
Publicado: (2015)

Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer’s Disease
por: Quinn, James P., et al.
Publicado: (2023)

Correction to “Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer’s Disease”
por: Quinn, James P., et al.
Publicado: (2023)

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
por: van Steenoven, Inger, et al.
Publicado: (2019)

JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
por: Musi, Clara Alice, et al.
Publicado: (2020)

Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases
por: Bivona, Giulia, et al.
Publicado: (2022)

Thyroid hormone and vitamin D regulate VGF expression and promoter activity
por: Lewis, Jo E, et al.
Publicado: (2016)

The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
por: Chan, Anthony W. S., et al.
Publicado: (2012)

Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters
por: Noli, Barbara, et al.
Publicado: (2015)

Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF
por: Mizoguchi, Takahiro, et al.
Publicado: (2017)

Structure of AQEE-30 of VGF Neuropeptide in Membrane-Mimicking Environments
por: Park, One-Sung, et al.
Publicado: (2022)

Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectives
por: Wang, Junhui
Publicado: (2023)

Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
por: Vallabh, Sonia M., et al.
Publicado: (2020)

NRF2 as a Therapeutic Target in Neurodegenerative Diseases
por: Brandes, Mikah S., et al.
Publicado: (2020)

Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis
por: Zhao, Zhong, et al.
Publicado: (2008)

Identification of a Receptor for Neuropeptide VGF and Its Role in Neuropathic Pain
por: Chen, Ya-Chun, et al.
Publicado: (2013)

Profiles of VGF Peptides in the Rat Brain and Their Modulations after Phencyclidine Treatment
por: Noli, Barbara, et al.
Publicado: (2017)

Therapeutic targeting of autophagy in neurodegenerative and infectious diseases
por: Rubinsztein, David C., et al.
Publicado: (2015)

Uncoupling Proteins as Therapeutic Targets for Neurodegenerative Diseases
por: Barnstable, Colin J., et al.
Publicado: (2022)

Shared mechanisms across the major psychiatric and neurodegenerative diseases
por: Wingo, Thomas S., et al.
Publicado: (2022)

Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine
por: Hayashi, Masamichi, et al.
Publicado: (2014)

VGF Peptide Profiles in Type 2 Diabetic Patients’ Plasma and in Obese Mice
por: D’Amato, Filomena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ug5i4dg0651tcb68dhe675nida